« Back to Record
Citation APA

Van Antwerpen, P., Legssyer, I., Zouaoui Boudjeltia, K., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2006). Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. European journal of pharmacology, 537(1-3), 31-36. doi:10.1016/j.ejphar.2006.03.022


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/67975

Van Antwerpen, P., Legssyer, I., Zouaoui Boudjeltia, K., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2006). Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. European journal of pharmacology, 537(1-3), 31-36. doi:10.1016/j.ejphar.2006.03.022